APA (7th ed.) Citation

Januszewicz, W., Pilonis, N. D., Phillips, R., O'Donovan, M., Sawas, T., Katzka, D. A., . . . Di Pietro, M. (2021). ID: 3523652 P53 IMMUNOHISTOCHEMISTRY REDUCES THE RATE OF INDEFINITE FOR DYSPLASIA DIAGNOSES IN BARRETT'S ESOPHAGUS ASSESSMENT AND IMPROVES THE INTEROBSERVER AGREEMENT AMONG HISTOPATHOLOGISTS. Gastrointestinal endoscopy, 93(6), AB288. https://doi.org/10.1016/j.gie.2021.03.603

Chicago Style (17th ed.) Citation

Januszewicz, Wladyslaw, et al. "ID: 3523652 P53 IMMUNOHISTOCHEMISTRY REDUCES THE RATE OF INDEFINITE FOR DYSPLASIA DIAGNOSES IN BARRETT'S ESOPHAGUS ASSESSMENT AND IMPROVES THE INTEROBSERVER AGREEMENT AMONG HISTOPATHOLOGISTS." Gastrointestinal Endoscopy 93, no. 6 (2021): AB288. https://doi.org/10.1016/j.gie.2021.03.603.

MLA (9th ed.) Citation

Januszewicz, Wladyslaw, et al. "ID: 3523652 P53 IMMUNOHISTOCHEMISTRY REDUCES THE RATE OF INDEFINITE FOR DYSPLASIA DIAGNOSES IN BARRETT'S ESOPHAGUS ASSESSMENT AND IMPROVES THE INTEROBSERVER AGREEMENT AMONG HISTOPATHOLOGISTS." Gastrointestinal Endoscopy, vol. 93, no. 6, 2021, p. AB288, https://doi.org/10.1016/j.gie.2021.03.603.